Modern Imaging in Prostate Cancer: When, Why, and How Often? скачать в хорошем качестве

Modern Imaging in Prostate Cancer: When, Why, and How Often?

A regional roundtable discussion, moderated by L. Crain Garrot, MD, Georgia Cancer Specialists, focused on the diagnostic and treatment landscape of metastatic hormone-sensitive prostate cancer (mHSPC). Dr. Garrot was joined by other Atlanta-based urologists and medical oncologists, including Shailesh Satpute, MD, PhD, Georgia Cancer Specialists; Yasin Bhanji, MD, Georgia Urology; Caroline Lu, MD, Georgia Urology; and Froylan Gonzalez, MD, Georgia Urology. In the first segment of the roundtable, the panel discusses the evolving role of PSMA PET scans, imaging intervals, and distinguishing hormone-sensitive from castration-resistant prostate cancer in clinical practice. The group also explores the challenges of relying on PSA levels alone for disease monitoring and navigating payer coverage for advanced imaging.